| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |